Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg
Conditions:   Coronary Artery Disease;   Dyslipidemias Intervention:   Drug: a high dose of statin/ezetimib Sponsors:   Yonsei University;   dotter Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials

A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants
Condition:   Healthy Interventions:   Drug: Rosuvastatin;   Drug: Selpercatinib Sponsor:   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials

Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg
Conditions:   Coronary Artery Disease;   Dyslipidemias Intervention:   Drug: a high dose of statin/ezetimib Sponsors:   Yonsei University;   dotter Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials

A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants
Condition:   Healthy Interventions:   Drug: Rosuvastatin;   Drug: Selpercatinib Sponsor:   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials

Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg
Conditions:   Coronary Artery Disease;   Dyslipidemias Intervention:   Drug: a high dose of statin/ezetimib Sponsors:   Yonsei University;   dotter Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials

A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants
Condition:   Healthy Interventions:   Drug: Rosuvastatin;   Drug: Selpercatinib Sponsor:   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2023 Category: Research Source Type: clinical trials

A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who Are Healthy Volunteers Co-administered the Medicine Rosuvastatin
Conditions:   Pharmacokinetics;   Healthy Volunteers Interventions:   Drug: Rosuvastatin;   Drug: Nirmatrelvir/ritonavir Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 12, 2023 Category: Research Source Type: clinical trials